Global Mammalian Cell Expression System Market Research Report 2025

Publication ID:

PB504251143

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Mammalian Cell Expression System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mammalian cell expression system is a type of recombinant protein expression system that uses genetically modified mammalian cells to produce large amounts of specific proteins. Mammalian cells are a popular choice for protein expression because they have the ability to perform post-translational modifications such as glycosylation, phosphorylation, and disulfide bond formation, which are important for the biological activity and stability of many proteins. Mammalian cell expression systems are widely used in the production of recombinant proteins for research, therapeutic, and industrial applications. They offer high protein expression levels, produce proteins with correct post-translational modifications, and are suitable for the production of complex and difficult-to-express proteins.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 314%.
This report aims to provide a comprehensive presentation of the global market for Mammalian Cell Expression System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Cell Expression System.
The Mammalian Cell Expression System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mammalian Cell Expression System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mammalian Cell Expression System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Profacgen
Creative BioMart
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Chinese Hamster Ovary (CHO) Cells
Human Embryonic Kidney (HEK) Cells
Mouse Myeloma Cells
BHK-21 Cells
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian Cell Expression System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian Cell Expression System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chinese Hamster Ovary (CHO) Cells
1.2.3 Human Embryonic Kidney (HEK) Cells
1.2.4 Mouse Myeloma Cells
1.2.5 BHK-21 Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Mammalian Cell Expression System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drugs Development
1.3.3 Biomedical Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian Cell Expression System Market Perspective (2020-2031)
2.2 Global Mammalian Cell Expression System Growth Trends by Region
2.2.1 Global Mammalian Cell Expression System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mammalian Cell Expression System Historic Market Size by Region (2020-2025)
2.2.3 Mammalian Cell Expression System Forecasted Market Size by Region (2026-2031)
2.3 Mammalian Cell Expression System Market Dynamics
2.3.1 Mammalian Cell Expression System Industry Trends
2.3.2 Mammalian Cell Expression System Market Drivers
2.3.3 Mammalian Cell Expression System Market Challenges
2.3.4 Mammalian Cell Expression System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian Cell Expression System Players by Revenue
3.1.1 Global Top Mammalian Cell Expression System Players by Revenue (2020-2025)
3.1.2 Global Mammalian Cell Expression System Revenue Market Share by Players (2020-2025)
3.2 Global Mammalian Cell Expression System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mammalian Cell Expression System Revenue
3.4 Global Mammalian Cell Expression System Market Concentration Ratio
3.4.1 Global Mammalian Cell Expression System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Expression System Revenue in 2024
3.5 Global Key Players of Mammalian Cell Expression System Head office and Area Served
3.6 Global Key Players of Mammalian Cell Expression System, Product and Application
3.7 Global Key Players of Mammalian Cell Expression System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Cell Expression System Breakdown Data by Type
4.1 Global Mammalian Cell Expression System Historic Market Size by Type (2020-2025)
4.2 Global Mammalian Cell Expression System Forecasted Market Size by Type (2026-2031)
5 Mammalian Cell Expression System Breakdown Data by Application
5.1 Global Mammalian Cell Expression System Historic Market Size by Application (2020-2025)
5.2 Global Mammalian Cell Expression System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mammalian Cell Expression System Market Size (2020-2031)
6.2 North America Mammalian Cell Expression System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mammalian Cell Expression System Market Size by Country (2020-2025)
6.4 North America Mammalian Cell Expression System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mammalian Cell Expression System Market Size (2020-2031)
7.2 Europe Mammalian Cell Expression System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mammalian Cell Expression System Market Size by Country (2020-2025)
7.4 Europe Mammalian Cell Expression System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Cell Expression System Market Size (2020-2031)
8.2 Asia-Pacific Mammalian Cell Expression System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mammalian Cell Expression System Market Size by Region (2020-2025)
8.4 Asia-Pacific Mammalian Cell Expression System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mammalian Cell Expression System Market Size (2020-2031)
9.2 Latin America Mammalian Cell Expression System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mammalian Cell Expression System Market Size by Country (2020-2025)
9.4 Latin America Mammalian Cell Expression System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Cell Expression System Market Size (2020-2031)
10.2 Middle East & Africa Mammalian Cell Expression System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mammalian Cell Expression System Market Size by Country (2020-2025)
10.4 Middle East & Africa Mammalian Cell Expression System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Mammalian Cell Expression System Introduction
11.1.4 Thermo Fisher Scientific Revenue in Mammalian Cell Expression System Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio Basic
11.2.1 Bio Basic Company Details
11.2.2 Bio Basic Business Overview
11.2.3 Bio Basic Mammalian Cell Expression System Introduction
11.2.4 Bio Basic Revenue in Mammalian Cell Expression System Business (2020-2025)
11.2.5 Bio Basic Recent Development
11.3 GenScript Biotech
11.3.1 GenScript Biotech Company Details
11.3.2 GenScript Biotech Business Overview
11.3.3 GenScript Biotech Mammalian Cell Expression System Introduction
11.3.4 GenScript Biotech Revenue in Mammalian Cell Expression System Business (2020-2025)
11.3.5 GenScript Biotech Recent Development
11.4 Oxford Expression Technologies
11.4.1 Oxford Expression Technologies Company Details
11.4.2 Oxford Expression Technologies Business Overview
11.4.3 Oxford Expression Technologies Mammalian Cell Expression System Introduction
11.4.4 Oxford Expression Technologies Revenue in Mammalian Cell Expression System Business (2020-2025)
11.4.5 Oxford Expression Technologies Recent Development
11.5 ProteoGenix
11.5.1 ProteoGenix Company Details
11.5.2 ProteoGenix Business Overview
11.5.3 ProteoGenix Mammalian Cell Expression System Introduction
11.5.4 ProteoGenix Revenue in Mammalian Cell Expression System Business (2020-2025)
11.5.5 ProteoGenix Recent Development
11.6 Promab Biotechnologies
11.6.1 Promab Biotechnologies Company Details
11.6.2 Promab Biotechnologies Business Overview
11.6.3 Promab Biotechnologies Mammalian Cell Expression System Introduction
11.6.4 Promab Biotechnologies Revenue in Mammalian Cell Expression System Business (2020-2025)
11.6.5 Promab Biotechnologies Recent Development
11.7 MTIBIO
11.7.1 MTIBIO Company Details
11.7.2 MTIBIO Business Overview
11.7.3 MTIBIO Mammalian Cell Expression System Introduction
11.7.4 MTIBIO Revenue in Mammalian Cell Expression System Business (2020-2025)
11.7.5 MTIBIO Recent Development
11.8 AMSBIO
11.8.1 AMSBIO Company Details
11.8.2 AMSBIO Business Overview
11.8.3 AMSBIO Mammalian Cell Expression System Introduction
11.8.4 AMSBIO Revenue in Mammalian Cell Expression System Business (2020-2025)
11.8.5 AMSBIO Recent Development
11.9 Kemp Proteins
11.9.1 Kemp Proteins Company Details
11.9.2 Kemp Proteins Business Overview
11.9.3 Kemp Proteins Mammalian Cell Expression System Introduction
11.9.4 Kemp Proteins Revenue in Mammalian Cell Expression System Business (2020-2025)
11.9.5 Kemp Proteins Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Mammalian Cell Expression System Introduction
11.10.4 Takara Bio Revenue in Mammalian Cell Expression System Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 Genosphere Biotechnologies
11.11.1 Genosphere Biotechnologies Company Details
11.11.2 Genosphere Biotechnologies Business Overview
11.11.3 Genosphere Biotechnologies Mammalian Cell Expression System Introduction
11.11.4 Genosphere Biotechnologies Revenue in Mammalian Cell Expression System Business (2020-2025)
11.11.5 Genosphere Biotechnologies Recent Development
11.12 Biocompare
11.12.1 Biocompare Company Details
11.12.2 Biocompare Business Overview
11.12.3 Biocompare Mammalian Cell Expression System Introduction
11.12.4 Biocompare Revenue in Mammalian Cell Expression System Business (2020-2025)
11.12.5 Biocompare Recent Development
11.13 Profacgen
11.13.1 Profacgen Company Details
11.13.2 Profacgen Business Overview
11.13.3 Profacgen Mammalian Cell Expression System Introduction
11.13.4 Profacgen Revenue in Mammalian Cell Expression System Business (2020-2025)
11.13.5 Profacgen Recent Development
11.14 Creative BioMart
11.14.1 Creative BioMart Company Details
11.14.2 Creative BioMart Business Overview
11.14.3 Creative BioMart Mammalian Cell Expression System Introduction
11.14.4 Creative BioMart Revenue in Mammalian Cell Expression System Business (2020-2025)
11.14.5 Creative BioMart Recent Development
11.15 Sino Biological
11.15.1 Sino Biological Company Details
11.15.2 Sino Biological Business Overview
11.15.3 Sino Biological Mammalian Cell Expression System Introduction
11.15.4 Sino Biological Revenue in Mammalian Cell Expression System Business (2020-2025)
11.15.5 Sino Biological Recent Development
11.16 Hangzhou Clongene Biotech
11.16.1 Hangzhou Clongene Biotech Company Details
11.16.2 Hangzhou Clongene Biotech Business Overview
11.16.3 Hangzhou Clongene Biotech Mammalian Cell Expression System Introduction
11.16.4 Hangzhou Clongene Biotech Revenue in Mammalian Cell Expression System Business (2020-2025)
11.16.5 Hangzhou Clongene Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Profacgen
Creative BioMart
Sino Biological
Hangzhou Clongene Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂